Clinical Trial Update: D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update for D07001 softgel-capsules in combination with capecitabine in advanced biliary tract cancer; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Capecitabine (Xeloda) (Capecitabine)
• D07001 Softgel-Capsules

Snippet

Sponsor: InnoPharmax Inc. | Conditions: Biliary Tract Cancer (BTC) | Phase 3 | Status: NOT_YET_RECRUITING